Dow Surges 300 Points; Johnson & Johnson Posts Upbeat Earnings
U.S. stocks traded mixed midway through trading, with the Nasdaq Composite declining over 1% on Thursday. The Dow traded up 0.87% to 35,365.00 wh...
Source: businessinsider.com
📰 Breakthrough Device News
Page 10 - Breakthrough Device News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Breakthrough Device. Real-time updates on events, politics, business and more.
What's Going On With T2 Biosystems Shares Today? - T2 Biosystems (NASDAQ:TTOO)
T2 Biosystems Inc (NASDAQ: TTOO) shares are trading higher Thursday after the FDA granted Breakthrough Device designation for the company's Candida auris
Source: benzinga.com
Nasdaq Down 50 Points; Tesla Earnings Beat Expectations - Durect (NASDAQ:DRRX), Netcapital (NASDAQ:NCPL)
U.S. stocks traded mixed this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.40% to 35,202.41 while the NASDAQ fell 0.35% to 14,307.57. The S&P 500, also fell, declining, 0.10% to 4 4,561.30.
Source: benzinga.com
Why Infosys Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - ABVC BioPharma (NASDAQ:ABVC), Alpine Summit Energy (NASDAQ:ALPS)
Gainers PainReform Ltd. (NASDAQ: PRFX) jumped 45.5% to $10.34 after declining 8% on Wednesday. PaiReform recently regained compliance with Nasdaq continued listing requirements.
Houston Division United States Infosys Limited Dynatronics Corporation Carvana Co Theseus Pharmaceuticals Inc
Source: benzinga.com
Diadem Presents Data at 2023 AAIC® Showing Its AlzoSure® Blood Test Can Identify Patients at High Risk of Significant Cognitive Decline Due to Alzheimer's Disease
—Data from 479-Patient Study Confirms Strong Prognostic Utility of AlzoSure® Predict for Identifying Whether or Not Individuals Will Experience a Significant...
Source: prnewswire.com
Optina's Landmark REPHRASE Study to Validate an Innovative Cerebral Amyloid Status Test for the Diagnosis and Management of Alzheimer's Disease
/PRNewswire/ -- Optina Diagnostics pioneering pivotal REPHRASE study, currently underway, is poised to revolutionize the diagnosis and management of...
Source: prnewswire.com
A Pathway for Medicare Coverage for Breakthrough Devices: Take Two | King & Spalding
On June 27, 2023, the Centers for Medicare & Medicaid Services (“CMS” or the “Agency”) issued a “Notice with Comment Period” (“Notice”) describing a new process for providing expedited...
Trump Administration Agency For Healthcare Research Evidence Development Plan Centers For Medicare Medicaid Services King Spalding Biden Administration
Source: jdsupra.com
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
/PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life threatening...
Charlesj Fisher Jr Jim Frakes Nicolas Gikakis Susan Noonan Company Contact University Of Pennsylvania
Source: prnewswire.com
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
SAN DIEGO, July 6, 2023 /PRNewswire/ -- Aethlon Medical, Inc. , a medical therapeutic company focused on developing products to treat cancer and life threatening infectious diseases, today announced...
Source: marketscreener.com
FDA Grants De Novo Marketing Authorization for
Simple Blood Test Aids Risk Assessment for Approximately 14 Million Eligible Patients in the United States Diabetic Kidney Disease is the Leading Cause of...
Source: globenewswire.com